정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2144 | Completed | At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 | Covid19 | Drug: bamlanivimab | Phase 4 | Daniel Griffin, Eli Lilly and Company, Optum, Inc. | INDUSTRY | 4000 | All | 65 Years | QueryLab, Minnetonka, Minnesota, United States |
| 2143 | Recruiting | Atorvastatin as Adjunctive Therapy in COVID-19 | COVID-19 | Drug: Atorvastatin | Phase 2 | Mount Auburn Hospital | OTHER | 300 | All | 18 Years ~ 85 Years | Mount Auburn Hospital, Cambridge, Massachusetts, United States |
| 2142 | Active, not recruiting | Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT | COVID-19 Pneumonia | Drug: Atorvastatin 40 Mg Oral Tablet Other: Placebo |
Phase 3 | Mansoura University | OTHER | 220 | All | 18 Years | Mansoura University Hospitals, Mansoura, Aldakahlia, Egypt |
| 2141 | Recruiting | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | Covid19 | Drug: Atovaquone/Azithromycin | Phase 2 | HonorHealth Research Institute | OTHER | 25 | All | 18 Years ~ 95 Years | HonorHealth, Scottsdale, Arizona, United States |
| 2140 | Completed | Atovaquone for Treatment of COVID-19 | COVID-19 | Drug: Experimental Group Drug: Placebo Group |
Phase 2 | University of Texas Southwestern Medical Center | OTHER | 61 | All | 18 Years | University of Texas Medical Center, Dallas, Texas, United States |
| 2139 | Recruiting | Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial | SARS-CoV-2 Infection (COVID-19) | Drug: Nafamostat Mesilate Biological: Hyperimmune Globulin Drug: Enoxaparin Drug: Dalteparin Drug: Tinzaparin |
Phase 3 | University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australasian Society for Infectious Diseases, Middlemore Clinical Trials, The George Institute, Hunter Medical Research Institute, The University of Queensland | OTHER | 2400 | All | 18 Years | Calvary Public Bruce Hospital, Bruce, Australian Capital Territory, Australia The Canberra Hospital, Canberra, Australian Capital Territory, Australia Armidale Hospital, Armidale, New South Wales, Australia Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia Blacktown Hospital, Blacktown, New South Wales, Australia Campbelltown Hospital, Campbelltown, New South Wales, Australia Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia The Sutherland Hospital, Caringbah, New South Wales, Australia Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia Northern Beaches Hospital, Frenchs Forest, New South Wales, Australia Griffith Base Hospital, Griffith, New South Wales, Australia Hornsby Ku-Ring Gai Hospital, Hornsby, New South Wales, Australia Nepean Hospital, Kingswood, New South Wales, Australia St George Hospital, Kogarah, New South Wales, Australia Liverpool Hospital, Liverpool, New South Wales, Australia John Hunter Hospital, New Lambton Heights, New South Wales, Australia Orange Health Service, Orange, New South Wales, Australia Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia Prince of Wales Hospital, Randwick, New South Wales, Australia Royal North Shore Hospital, St Leonards, New South Wales, Australia The Tweed Hospital, Tweed Heads, New South Wales, Australia Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia Calvary Mater Newcastle, Waratah, New South Wales, Australia Westmead Hospital, Westmead, New South Wales, Australia Wollongong Hospital, Wollongong, New South Wales, Australia Royal Darwin Hospital, Tiwi, Northern Territory, Australia Sunshine Coast University Hospital, Birtinya, Queensland, Australia The Prince Charles Hospital, Chermside, Queensland, Australia Royal Brisbane and Women's Hospital, Herston, Queensland, Australia Gold Coast University Hospital, Southport, Queensland, Australia Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia Royal Hobart Hospital, Hobart, Tasmania, Australia Launceston General Hospital, Launceston, Tasmania, Australia Ballarat Health Services, Ballarat Central, Victoria, Australia St John of God Ballarat Hospital, Ballarat, Victoria, Australia Bendigo Health, Bendigo, Victoria, Australia Eastern Health (Box Hill Hospital), Box Hill, Victoria, Australia Monash Health, Clayton, Victoria, Australia Northern Health, Epping, Victoria, Australia St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia Frankston Hospital - Penninsula Health, Frankston, Victoria, Australia Peninsula Private Hospital, Frankston, Victoria, Australia Barwon Health - University Hospital Geelong, Geelong, Victoria, Australia Austin Health, Heidelberg, Victoria, Australia Cabrini Health, Malvern, Victoria, Australia Alfred Hospital, Melbourne, Victoria, Australia Royal Melbourne Hospital, Parkville, Victoria, Australia Epworth Richmond, Richmond, Victoria, Australia Goulburn Valley Health, Shepparton, Victoria, Australia Western Health, St Albans, Victoria, Australia Latrobe Regional Hospital, Traralgon, Victoria, Australia West Gippsland Hospital, Warragul, Victoria, Australia Albury Wodonga Health, Wodonga, Victoria, Australia Rockingham General Hospital, Cooloongup, Western Australia, Australia Joondalup Health Campus, Joondalup, Western Australia, Australia Armadale Health Service, Mount Nasura, Western Australia, Australia Fiona Stanley Hospita, Murdoch, Western Australia, Australia Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia Royal Perth Hospital, Perth, Western Australia, Australia St John of God Subiaco Hospital, Subiaco, Western Australia, Australia |
| 2138 | Recruiting | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | COVID-19 | Drug: Chloroquine or Hydroxychloroquine Drug: Lopinavir/Ritonavir Other: Best standard of care Drug: Rivaroxaban Drug: Thromboprophylaxis Drug: Candesartan Drug: non-RAS blocking antihypertensives Drug: Remdesivir Drug: Asunercept 400mg Drug: Asunercept 100mg Drug: Asunercept 25mg Drug: Pentaglobin |
Phase 3 | Medical University of Vienna, Kaiser Franz Josef Hospital, SMZ-Ost Donauspital, Otto Wagner Hospital, Hospital Hietzing, Wilhelminenspital Vienna, Medical University Innsbruck, Medical University of Graz, Kepler University Hospital | OTHER | 500 | All | 18 Years ~ 99 Years | Medical University of Innsbruck, Innsbruck, Tirol, Austria Medical University of Graz, Graz, Austria Kepler University Hospital, Linz, Austria Medical University of Vienna, Vienna, Austria Wilhelminenspital, Vienna, Austria SMZ Sud Kaiser Franz Josef Spital, Vienna, Austria KH Hietzing, Vienna, Austria SMZ Baumgartner Hohe Otto Wagner Spital, Vienna, Austria SMZ Ost Donauspital, Vienna, Austria |
